Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S L Hauser

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Neurology|May 25, 2011
Vitamin D in African Americans with multiple sclerosisJ M Gelfand, B A C Cree, J McElroy, et al.
The Journal of Clinical Investigation|September 1, 1994
In healthy primates, circulating autoreactive T cells mediate autoimmune diseaseC P Genain, D Lee-Parritz, M H Nguyen, et al.
Neurology|July 26, 2006
Men transmit MS more often to their children vs women: the Carter effectO H Kantarci, L F Barcellos, E J Atkinson, et al.
Neurology|May 1, 1993
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.
Human Immunology|September 15, 1996
Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretionA Garcia-Merino, C A Alper, K Usuku, et al.
Neurology|May 10, 2000
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study GroupS L Hauser, J R Oksenberg, R Lincoln, et al.
Genes and Immunity|June 10, 2011
SNP-based analysis of the HLA locus in Japanese multiple sclerosis patientsJ P McElroy, N Isobe, P A Gourraud, et al.
Genes and Immunity|May 23, 2003
Osteopontin polymorphisms and disease course in multiple sclerosisS Caillier, L F Barcellos, S E Baranzini, et al.
Genes and Immunity|June 27, 2008
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosisL F Barcellos, P P Ramsay, S J Caillier, et al.
Nature Genetics|August 31, 2001
PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patientsL F Barcellos, S Caillier, L Dragone, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Neurology|May 25, 2011
Vitamin D in African Americans with multiple sclerosisJ M Gelfand, B A C Cree, J McElroy, et al.
The Journal of Clinical Investigation|September 1, 1994
In healthy primates, circulating autoreactive T cells mediate autoimmune diseaseC P Genain, D Lee-Parritz, M H Nguyen, et al.
Neurology|July 26, 2006
Men transmit MS more often to their children vs women: the Carter effectO H Kantarci, L F Barcellos, E J Atkinson, et al.
Neurology|May 1, 1993
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment GroupH L Weiner, G A Mackin, E J Orav, et al.
Human Immunology|September 15, 1996
Tumor necrosis factor (TNF) microsatellite haplotypes in relation to extended haplotypes, susceptibility to diseases associated with the major histocompatibility complex and TNF secretionA Garcia-Merino, C A Alper, K Usuku, et al.
Neurology|May 10, 2000
Interaction between HLA-DR2 and abnormal brain MRI in optic neuritis and early MS. Optic Neuritis Study GroupS L Hauser, J R Oksenberg, R Lincoln, et al.
Genes and Immunity|June 10, 2011
SNP-based analysis of the HLA locus in Japanese multiple sclerosis patientsJ P McElroy, N Isobe, P A Gourraud, et al.
Genes and Immunity|May 23, 2003
Osteopontin polymorphisms and disease course in multiple sclerosisS Caillier, L F Barcellos, S E Baranzini, et al.
Genes and Immunity|June 27, 2008
Genetic variation in nitric oxide synthase 2A (NOS2A) and risk for multiple sclerosisL F Barcellos, P P Ramsay, S J Caillier, et al.
Nature Genetics|August 31, 2001
PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patientsL F Barcellos, S Caillier, L Dragone, et al.
Pageof 14